ZLAB

Zai Lab

No price yet

Announcements

Nothing here yet

Daily updates

Nothing here yet

FDA designations

Nothing here yet

News

Zai Lab to present data from the first clinical trial of ZL-1503, a bispecific IL-13/IL-31Rα antibody, for atopic diseasesOct 14, 2026
Zai Lab and argenx announced positive topline results from the Phase 3 ALKIVIA trial of efgartigimod in autoimmune myositisAug 17, 2026
FDA granted Orphan Drug designation to Zai Lab's DLL3-targeting ADC Zocilurtatug Pelitecan for neuroendocrine carcinomasAug 3, 2026
Zai Lab received EMA orphan drug designation for Zocilurtatug Pelitecan in pulmonary neuroendocrine carcinomasJun 16, 2026
Zai Lab receives FDA Fast Track designation for DLL3-targeting ADC Zoci in extrapulmonary neuroendocrine carcinomasMay 11, 2026